What is the recommended dose of doxycycline (DOXY) for the treatment of Methicillin-resistant Staphylococcus aureus (MRSA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Doxycycline Dosing for MRSA Infections

For treatment of MRSA infections, doxycycline should be administered at a dose of 100 mg twice daily orally for adults. 1

Adult Dosing

  • Doxycycline 100 mg orally twice daily for MRSA skin and soft tissue infections (SSTIs) 1
  • For purulent cellulitis caused by MRSA, doxycycline 100 mg orally twice daily is recommended 1
  • Duration of therapy is typically 7-10 days but should be adjusted based on clinical response 1
  • For complicated MRSA infections requiring intravenous therapy, doxycycline can be administered at 100 mg every 12 hours intravenously 1

Pediatric Considerations

  • Doxycycline is not recommended for children under 8 years of age due to risk of dental staining 1
  • For children ≥8 years: 2 mg/kg/dose orally every 12 hours (not to exceed adult dose) 1
  • For children >45 kg: use adult dosing of 100 mg twice daily 1

Clinical Efficacy

  • Doxycycline is considered bacteriostatic against MRSA 1
  • It is an effective alternative to trimethoprim-sulfamethoxazole (TMP-SMX) for outpatient treatment of MRSA SSTIs 1, 2
  • In areas where tetracycline resistance is low, doxycycline has shown good clinical outcomes for community-acquired MRSA infections 2

Important Considerations

  • Always check local susceptibility patterns before prescribing doxycycline for MRSA 2
  • Tetracycline susceptibility testing can predict doxycycline susceptibility 2
  • Doxycycline may be preferred over TMP-SMX in some cases due to better tolerability 3
  • Resistance can emerge during therapy, particularly with monotherapy 4

Alternative Options for MRSA

  • Clindamycin 300-450 mg orally three times daily (if susceptible) 1
  • TMP-SMX 1-2 double-strength tablets twice daily 1
  • Linezolid 600 mg orally twice daily (more expensive option) 1
  • Minocycline 200 mg initially, then 100 mg orally twice daily (alternative tetracycline) 1, 3

Treatment Failures

  • If treatment failure occurs with doxycycline, consider:
    • Performing incision and drainage if abscess is present 1
    • Checking for antimicrobial susceptibility 2
    • Switching to an alternative agent like linezolid or vancomycin for severe infections 1
    • Adding rifampin in select cases of persistent infection 5

Doxycycline remains a valuable oral option for MRSA infections, particularly for outpatient management of skin and soft tissue infections when the organism is susceptible.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.